These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Bihari K Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212 [TBL] [Abstract][Full Text] [Related]
3. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study). Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065 [TBL] [Abstract][Full Text] [Related]
4. Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients. Poungvarin N; Viriyavejakul A J Med Assoc Thai; 1994 Sep; 77(9):464-70. PubMed ID: 7706965 [TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis]. Wissel J; Entner T Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048 [TBL] [Abstract][Full Text] [Related]
6. Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients. Greene PE; Fahn S Mov Disord; 1996 Mar; 11(2):181-4. PubMed ID: 8684389 [TBL] [Abstract][Full Text] [Related]
7. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections. Sankhla C; Jankovic J; Duane D Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin in the treatment of dystonic tics. Jankovic J Mov Disord; 1994 May; 9(3):347-9. PubMed ID: 8041378 [TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor. Wissel J; Masuhr F; Schelosky L; Ebersbach G; Poewe W Mov Disord; 1997 Sep; 12(5):722-6. PubMed ID: 9380055 [TBL] [Abstract][Full Text] [Related]
11. Treatment of cervical dystonia (torticollis) in adults with botulinum A toxin. Metzer WS; Jenkins T J Ark Med Soc; 1992 Aug; 89(3):133-4. PubMed ID: 1517180 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of Botox and a Chinese type a botulinum toxin in cervical dystonia]. Wan X; Tang X Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):131-4. PubMed ID: 10923426 [TBL] [Abstract][Full Text] [Related]
14. Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia. Birkent H; Maronian N; Waugh P; Merati AL; Perkel D; Hillel AD Otolaryngol Head Neck Surg; 2009 Jan; 140(1):43-7. PubMed ID: 19130960 [TBL] [Abstract][Full Text] [Related]
15. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients]. Novis SA; De Mattos JP; De Rosso AL Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159 [TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia. Quagliato EM; Carelli EF; Viana MA Clin Neuropharmacol; 2010; 33(1):22-6. PubMed ID: 19959960 [TBL] [Abstract][Full Text] [Related]
18. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group]. Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of spasmodic torticollis by local injections of botulinum toxin]. Jedynak CP; de Saint Victor JF Rev Neurol (Paris); 1990; 146(6-7):440-3. PubMed ID: 2399409 [TBL] [Abstract][Full Text] [Related]
20. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]